Your browser is no longer supported. Please, upgrade your browser.
NUVA NuVasive, Inc. daily Stock Chart
NuVasive, Inc.
Index- P/E64.04 EPS (ttm)1.00 Insider Own0.20% Shs Outstand51.86M Perf Week-3.56%
Market Cap3.30B Forward P/E24.84 EPS next Y2.57 Insider Trans-8.87% Shs Float51.65M Perf Month9.56%
Income52.40M PEG6.16 EPS next Q0.54 Inst Own- Short Float6.90% Perf Quarter4.49%
Sales1.13B P/S2.93 EPS this Y-78.80% Inst Trans-0.49% Short Ratio8.95 Perf Half Y8.76%
Book/sh16.60 P/B3.84 EPS next Y10.51% ROA3.00% Target Price65.56 Perf Year-5.31%
Cash/sh2.48 P/C25.74 EPS next 5Y10.40% ROE6.30% 52W Range43.51 - 72.41 Perf YTD28.57%
Dividend- P/FCF27.20 EPS past 5Y7.10% ROI4.00% 52W High-12.00% Beta1.18
Dividend %- Quick Ratio2.00 Sales past 5Y10.00% Gross Margin72.30% 52W Low46.45% ATR1.98
Employees2600 Current Ratio3.60 Sales Q/Q3.70% Oper. Margin8.40% RSI (14)55.28 Volatility2.52% 3.16%
OptionableYes Debt/Eq0.00 EPS Q/Q28.50% Profit Margin4.70% Rel Volume0.85 Prev Close63.13
ShortableYes LT Debt/Eq0.71 EarningsJul 30 AMC Payout0.00% Avg Volume398.22K Price63.72
Recom2.70 SMA201.30% SMA506.53% SMA20011.65% Volume338,427 Change0.93%
Jul-29-19Downgrade Robert W. Baird Outperform → Neutral $66
Feb-12-19Downgrade Jefferies Buy → Hold $60
Feb-08-19Downgrade Needham Buy → Hold
Oct-31-18Reiterated Needham Buy $80 → $75
Oct-17-18Reiterated Needham Buy $67 → $80
Sep-27-18Upgrade Robert W. Baird Neutral → Outperform
Aug-01-18Reiterated Needham Buy $69 → $67
Jun-27-18Downgrade BofA/Merrill Neutral → Underperform
Jun-21-18Downgrade JP Morgan Overweight → Neutral
Jun-01-18Initiated Cantor Fitzgerald Neutral
May-02-18Reiterated Needham Buy $70 → $69
Apr-04-18Initiated Goldman Neutral $47
Feb-27-18Reiterated Needham Buy $71 → $70
Feb-01-18Downgrade Leerink Partners Outperform → Mkt Perform
Jan-17-18Downgrade Wells Fargo Outperform → Market Perform
Jan-04-18Upgrade Needham Underperform → Buy $71
Nov-10-17Reiterated RBC Capital Mkts Outperform $75 → $70
Oct-25-17Reiterated Canaccord Genuity Buy $75 → $70
Sep-07-17Initiated BTIG Research Buy $82
Aug-28-17Downgrade Needham Hold → Underperform
Aug-16-19 09:52AM  Here's Why You Should Hold Onto Omnicell (OMCL) Stock for Now Zacks
09:51AM  QIAGEN Posts QIAstat-Dx Gastrointestinal Panel Study Results Zacks
Aug-15-19 09:13AM  Baxter's PrisMax Adopted by Hamilton Health Care System Zacks
Aug-14-19 12:14PM  CVS Health Banks on Health Care Benefit Prospects Amid Woes Zacks
09:40AM  ResMed (RMD) Hits a New 52-Week High: What's Driving It? Zacks
09:35AM  Here's Why You Should Hold Onto Insulet (PODD) Stock for Now Zacks
08:30AM  NuVasive Specialized Orthopedics Reaches 10,000 Nail Implant Milestone of the Precice® System for Limb Lengthening PR Newswire
Aug-13-19 10:18AM  Boston Scientific Rides on New Products Amid Dull Pacer Sales Zacks
09:35AM  Baxter (BAX) Hits 52-Week High, Can the Run Continue? Zacks
09:10AM  Canopy Growth Set to Acquire Beckley Canopy Therapeutics Zacks
Aug-12-19 08:41AM  National Vision (EYE) Q2 Earnings Lag Estimates, Margins Down Zacks
Aug-09-19 02:26PM  Why NuVasive Stock Gained 14% in July Motley Fool
07:32AM  Haemonetics (HAE) Beats on Q1 Earnings, Raises '19 EPS View Zacks
Aug-08-19 06:00AM  NuVasive Presents Long-Term Strategy and Financial Outlook at 2019 Investor Day PR Newswire
Aug-06-19 09:30AM  NUVA vs. RMD: Which Stock Is the Better Value Option? Zacks
Aug-02-19 07:54AM  Will NuVasive Continue to Surge Higher? Zacks
Aug-01-19 02:07PM  Is NuVasive (NASDAQ:NUVA) Using Too Much Debt? Simply Wall St.
Jul-31-19 01:15PM  Why NuVasive Stock Is Shooting Higher Today Motley Fool +10.96%
01:11PM  Edited Transcript of NUVA earnings conference call or presentation 30-Jul-19 8:30pm GMT Thomson Reuters StreetEvents
09:23AM  NuVasive Inc (NUVA) Q2 2019 Earnings Call Transcript Motley Fool
09:08AM  NuVasive (NUVA) Earnings and Revenues Beat Estimates in Q2 Zacks
08:23AM  NuVasive Sees a Healthier Future Motley Fool
Jul-30-19 06:05PM  NuVasive (NUVA) Tops Q2 Earnings and Revenue Estimates Zacks
04:02PM  NuVasive Announces Second Quarter 2019 Financial Results PR Newswire
02:30PM  NuVasive, Inc. to Host Earnings Call ACCESSWIRE
07:02AM  Buy 6 Top Stocks Set to Beat on Earnings in Q2 Today Zacks
Jul-26-19 10:10AM  Why the Earnings Surprise Streak Could Continue for NuVasive (NUVA) Zacks
Jul-23-19 10:32AM  NuVasive (NUVA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Jul-17-19 09:17AM  Henry Schein Closes Acquisition of Elite Computer Italia Zacks
08:51AM  NextGen Inks Deal With Appriss Health, Boosts EHR System Zacks
Jul-16-19 08:47AM  Intuitive Surgical to Boost da Vinci Platform With Buyout Zacks
08:39AM  Chemed's Roto-Rooter & VITAS Robust, Acuity Mix Shift Weak Zacks
07:59AM  Masimo (MASI) Hits a 52-Week High on Solid Growth Drivers Zacks
07:45AM  Abbott MitraClip G4 Gets FDA Nod, Valve Repair Options Expand Zacks
Jul-15-19 04:05PM  NuVasive Announces Conference Call and Webcast of Second Quarter 2019 Results PR Newswire
09:12AM  ABT or BIO: Which Stock Has Better Potential Right Now? Zacks
08:33AM  Here's Why You Should Hold Onto Neogen (NEOG) Stock Now Zacks
08:30AM  Evolus Expands Board of Directors with Appointment of Independent Directors Peter Farrell, Ph.D. and Karah Parschauer, J.D. GlobeNewswire
Jul-12-19 08:54AM  TFX or STE: Which is a Better Investment Pick Right Now? Zacks
Jul-11-19 08:30AM  NuVasive to Participate as Double Diamond Sponsor at 2019 International Meeting on Advanced Spine Techniques PR Newswire
07:19AM  NuVasive (NUVA) Launches Pulse Integrated Technology Platform Zacks
Jul-10-19 08:30AM  NuVasive Launches Pulse-The First Integrated Technology Platform to Enable Better Spine Surgery PR Newswire
06:10AM  At US$55.78, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List? Simply Wall St.
Jun-20-19 12:09PM  Heres What Hedge Funds Think About NuVasive, Inc. (NUVA) Insider Monkey
06:59AM  Was NuVasive, Inc.'s (NASDAQ:NUVA) Earnings Growth Better Than The Industry's? Simply Wall St.
Jun-18-19 10:22AM  NuVasive Grows on Strong Product Adoption Amid Pricing Woe Zacks
07:27AM  NuVasive Launches Titanium Spine Implant Modulus TLIF-O Zacks
Jun-17-19 08:30AM  NuVasive Expands Advanced Materials Science Portfolio with Launch of Porous Titanium Spine Implant for Transforaminal Lumbar Interbody Fusion PR Newswire
Jun-12-19 08:30AM  NuVasive LessRay® Platform Wins Gold at 2019 Medical Design Excellence Awards PR Newswire
May-31-19 09:31AM  Why Is NuVasive (NUVA) Down 3.9% Since Last Earnings Report? Zacks
May-30-19 08:30AM  NuVasive SpineTRACK Registry Successfully Meets 2018 Medicare Reporting Requirements For Merit-based Incentive Payments System PR Newswire
May-29-19 09:47AM  Is NuVasive, Inc. (NASDAQ:NUVA) A Financially Sound Company? Simply Wall St.
May-28-19 03:39PM  Edited Transcript of NUVA earnings conference call or presentation 1-May-19 8:30pm GMT Thomson Reuters StreetEvents
08:55AM  Here's Why You Should Retain NuVasive (NUVA) Stock for Now Zacks
May-14-19 09:30AM  VREX vs. NUVA: Which Stock Is the Better Value Option? Zacks
08:30AM  NuVasive To Participate As Global Partner At 12th Annual Society Of Lateral Access Surgery Meeting PR Newswire
May-06-19 04:05PM  NuVasive To Present At The Bank of America Merrill Lynch Healthcare Conference 2019 PR Newswire
08:20AM  How NuVasive, Inc. (NASDAQ:NUVA) Can Impact Your Portfolio Volatility Simply Wall St.
May-02-19 11:37AM  NuVasive (NUVA) Q1 Earnings Top Estimates, Margins Strong Zacks
05:35AM  NuVasive Inc (NUVA) Q1 2019 Earnings Call Transcript Motley Fool
May-01-19 08:05PM  NuVasive Straightens Up to Start 2019 Motley Fool
06:05PM  NuVasive (NUVA) Q1 Earnings and Revenues Top Estimates Zacks
04:55PM  NuVasive: 1Q Earnings Snapshot Associated Press
04:02PM  NuVasive Announces First Quarter 2019 Financial Results PR Newswire
11:53AM  A Preview Of NuVasive's Q1 Earnings Benzinga
Apr-29-19 09:45AM  Is NuVasive, Inc. (NUVA) A Good Stock To Buy? Insider Monkey
Apr-24-19 10:33AM  NuVasive (NUVA) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Apr-22-19 08:30AM  Clinical Study Demonstrates NuVasive Cohere® Porous PEEK Spinal Interbody Promotes Improved Early Outcomes Over Structural Allograft And Smooth PEEK PR Newswire
Apr-15-19 04:05PM  NuVasive Announces Conference Call And Webcast Of First Quarter 2019 Results PR Newswire
Apr-11-19 05:30AM  Nuvasive Advances Lateral Single-Position Surgery With Introduction Of X360 System At AANS 2019 PR Newswire
Apr-05-19 08:30AM  NuVasive LessRay® Platform Wins Top Honor At 2019 Edison Awards PR Newswire
Apr-02-19 10:50AM  NuVasive (NUVA) Completes First COHERE XLIF Case in U.S. Zacks
Apr-01-19 08:30AM  NuVasive Proprietary Porous PEEK Technology Used In First XLIF® Spine Surgery Cases PR Newswire
Mar-22-19 09:30AM  NuVasive (NUVA) Down 1% Since Last Earnings Report: Can It Rebound? Zacks
Mar-12-19 03:30PM  Options Bears Jump on Battered NuVasive Stock Schaeffer's Investment Research -5.84%
Mar-06-19 04:05PM  NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At Spine Summit 2019 PR Newswire
01:39PM  Why NuVasive Stock Rose 18% in February Motley Fool
07:55AM  Research Report Identifies E*TRADE Financial, Kennedy-Wilson, Alteryx, PTC Therapeutics, Ocean Power Technologies, and NuVasive with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-05-19 04:05PM  NuVasive To Participate In Cowen And Company 39th Annual Health Care Conference PR Newswire
Feb-25-19 02:11AM  Edited Transcript of NUVA earnings conference call or presentation 20-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-22-19 07:50AM  NuVasive (NUVA) Q4 Earnings Beat Estimates, Margins Fall Zacks
Feb-21-19 04:05PM  NuVasive To Present At 8th Annual Leerink Partners Global Healthcare Conference PR Newswire
02:17PM  NuVasive (NUVA) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-20-19 06:21PM  NuVasive Overcomes Industry Headwinds to Finish 2018 Strong Motley Fool
05:40PM  NuVasive (NUVA) Q4 Earnings and Revenues Top Estimates Zacks
04:34PM  NuVasive: 4Q Earnings Snapshot Associated Press
04:02PM  NuVasive Reports Fourth Quarter And Full Year 2018 Financial Results PR Newswire
02:30PM  NuVasive, Inc. to Host Earnings Call ACCESSWIRE
Feb-19-19 08:30AM  NuVasive's Proprietary Magnetic Implant System To Be Used In First-Of-Its-Kind, All-Internal Bone Transport System PR Newswire
Feb-13-19 10:31AM  NuVasive (NUVA) Earnings Expected to Grow: Should You Buy? Zacks
07:50AM  New Research: Key Drivers of Growth for Plains Group Holdings, Cooper Tire & Rubber, NuVasive, Envestnet, Pacific Ethanol, and Mistras Group Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Feb-12-19 10:21AM  Jefferies Downgrades NuVasive, Says M&A Unlikely To Materialize Benzinga
12:00AM  [$$] Morgan Stanley tests M&A waters with millennial millionaires play Financial Times
Feb-11-19 04:34PM  Why NuVasive, Avis Budget Group, and Insperity Jumped Today Motley Fool +13.26%
04:20PM  NuVasive Stock Surges on Report of Smith & Nephew Interest
04:17PM  Medical Stock Pops On Potential $3 Billion Smith & Nephew Takeover Investor's Business Daily
01:33PM  Heres why NuVasive, Inc.s (NASDAQ:NUVA) Returns On Capital Matters So Much Simply Wall St.
11:44AM  NuVasive Stock Shoots Higher on Takeover Talk InvestorPlace
10:45AM  Here's Why NuVasive Stock Is Soaring Today Motley Fool
09:58AM  Smith & Nephew Drops on Report of Deal Talks With NuVasive Bloomberg
NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The company's principal products include Maximum Access Surgery, a minimally disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons to access the spine to perform restorative and fusion procedures in a minimally-disruptive fashion. The company's biologics products include Osteocel Plus and Pro, a cellular bone matrix; Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; and Propel DBM, a moldable demineralized bone matrix putty and gel. Its IOM services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also provides implants used for interbody disc height restoration; and fixation products, including pedicle screws, rods, and plates. In addition, it offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis, a spinal bracing and distraction system; and PRECICE, a limb lengthening system. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly-employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SISITSKY NATHANIELSVP & General CounselJul 01Option Exercise0.001,71009,957Jul 03 05:52 PM
Rosenberg Donald JDirectorJun 01Option Exercise0.003,23009,193Jun 04 05:53 PM
LUCIER GREGORY TDirectorMay 22Option Exercise0.0078,7020270,709May 24 05:53 PM
Huennekens R ScottDirectorMay 09Option Exercise0.001,36001,360May 10 05:47 PM
OHALLERAN MICHAEL DDirectorMay 03Option Exercise0.003,230018,816May 07 05:52 PM
Link MatthewPresidentMay 02Sale62.0010,100626,20083,143May 06 05:55 PM
McClintock PaulPresident, U.S. CommercialApr 01Option Exercise0.005,06505,465Apr 03 05:54 PM
SISITSKY NATHANIELSVP & General CounselMar 01Option Exercise0.004,95009,579Mar 05 05:57 PM
Vitale LucasChief Human Resources OfficerMar 01Option Exercise0.003,99206,799Mar 05 05:55 PM
Link MatthewPresidentMar 01Option Exercise0.0019,1570100,074Mar 05 05:48 PM
LUCIER GREGORY TDirectorMar 01Option Exercise0.0079,8140230,776Mar 05 05:44 PM
Link MatthewPresident, Strat/Tech/Corp DevDec 17Option Exercise34.8250017,41079,616Dec 19 05:55 PM
Link MatthewPresident, Strat/Tech/Corp DevNov 21Sale62.224,889304,19479,116Nov 26 05:57 PM
Link MatthewPresident, Strat/Tech/Corp DevNov 19Sale62.021,38285,71284,005Nov 20 05:56 PM
Link MatthewPresident, Strat/Tech/Corp DevNov 16Sale62.011,20074,41285,387Nov 20 05:56 PM